Sun Pharma, including its subsidiaries or associate companies today announced the signing of a tri-party agreement among the Indian Council of Medical Research, Madhya Pradesh Government and the Foundation for Disease Elimination and Control of India (FDEC-INDIA) to launch the Malaria Free India demonstration project in Mandla district.
The Foundation for Disease Elimination and Control of India (FDEC-INDIA) has been established by Sun Pharma for disease elimination and control initiatives as part of its CSR programme.
The Malaria Free India initiative was announced in April 2016 as part of the broader MOU signed between ICMR and Sun Pharma for development of translational health sciences and disease control & elimination. ICMR’s National Institute for Research in Tribal Health is one of its permanent national institute situated in Jabalpur with the mandate to plan, conduct and coordinate research on specific health problems and health needs of the tribals. The Institute is also WHO Collaborative Centre for the Health of the Indigenous populations. According to the Agreement signed, NIRTH, MP Government and FDEC-India will jointly accomplish the goals of malaria elimination from Mandla district and prevent re-introduction by use of vector control (Indoor residual spray and/or use of insecticide treated long-lasting bednets (llINs) and case management (rapid on-the-spot diagnosis and prompt treatment) as per national and/or WHO norms of malaria elimination efforts.
FDEC-India will be responsible for implementation of the Project in an independent manner in collaboration with NIRTH/ICMR, MP Government and all appropriate stakeholders. It will execute the malaria elimination project over a span of 3 to 5 years covering 1,233 villages in Mandla district.
The Malaria Free India demonstration project in Mandla is expected to be launched by January 2017.